4D PHARMA PLC

Company number 08840579

Date	Type	Description	View / Download
01 Oct 2021	MA	Memorandum and Articles of Association	(72 pages)
11 Aug 2021	MR01	Registration of charge 088405790004, created on 29 July 2021	(32 pages)
10 Aug 2021	MR01	Registration of charge 088405790002, created on 29 July 2021	(55 pages)
10 Aug 2021	MR01	Registration of charge 088405790003, created on 29 July 2021	(95 pages)
05 Aug 2021	MR01	Registration of charge 088405790001, created on 29 July 2021	(37 pages)
20 Jun 2021	AA	Group of companies' accounts made up to 31 December 2020	(84 pages)
17 Jun 2021	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES13 ‐ Accounts received / directors and auditor reappointed / directors authorised to determine auditor remuneration / authority to make market purchases 24/05/2021	(2 pages)
17 Jun 2021	SH01	Statement of capital following an allotment of shares on 21 April 2021 GBP 450,752.4175	(3 pages)
17 May 2021	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(2 pages)
29 Apr 2021	SH01	Statement of capital following an allotment of shares on 22 April 2021 GBP 450,749.32	(3 pages)
21 Apr 2021	SH01	Statement of capital following an allotment of shares on 23 March 2021 GBP 447,455.12	(3 pages)
15 Apr 2021	SH01	Statement of capital following an allotment of shares on 5 March 2020 GBP 328,916.31	(3 pages)
11 Mar 2021	AP01	Appointment of Paul Victor Maier as a director on 1 March 2021	(2 pages)
04 Feb 2021	SH01	Statement of capital following an allotment of shares on 25 January 2021 GBP 328,746.3875	(3 pages)
13 Jan 2021	CS01	Confirmation statement made on 6 January 2021 with no updates	(3 pages)
13 Jan 2021	SH01	Statement of capital following an allotment of shares on 22 October 2020 GBP 328,669.8375	(3 pages)
08 Oct 2020	AP01	Appointment of Katrin Rupalla as a director on 18 August 2020	(2 pages)
08 Oct 2020	TM01	Termination of appointment of David Robert Norwood as a director on 30 September 2020	(1 page)
17 Jul 2020	SH01	Statement of capital following an allotment of shares on 16 July 2020 GBP 328,480.605	(3 pages)
10 Jul 2020	AA	Group of companies' accounts made up to 31 December 2019	(88 pages)
08 Jul 2020	RESOLUTIONS	Resolutions RES13 ‐ Market purchases of its ordinary shares to a maximum of 10949384 ordinary shares of not less than 0.25 pence and not more than 5% above the average of the mid market quotations for ordinary shares.receive and adopt the company's annual accounts. To reappoint directors.reappoint auditors. 30/06/2020 RES10 ‐ Resolution of allotment of securities	(2 pages)
08 Jul 2020	RESOLUTIONS	Resolutions RES13 ‐ Market purchases of its ordinary shares to a maximum of 10949384 ordinary shares of not less than 0.25 pence and not more than 5% above the average of the mid market quotations for ordinary shares.receive and adopt the company's annual accounts. To reappoint directors.reappoint auditors. 30/06/2020 RES10 ‐ Resolution of allotment of securities	(2 pages)
03 Jul 2020	SH01	Statement of capital following an allotment of shares on 9 March 2020 GBP 163,734.605	(3 pages)
29 Jun 2020	TM01	Termination of appointment of Thomas Engelen as a director on 21 May 2020	(1 page)
21 Apr 2020	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	(1 page)